Электронный архив

Просмотр по автору "Muguruma K."

Просмотр по автору "Muguruma K."

Отсортировать по:Сортировать:Результаты поиска на странице:

  • Disease-associated acrolein: A possible diagnostic and therapeutic substrate for in vivo synthetic chemistry 
    Muguruma K.; Pradipta A.R.; Ode Y.; Terashima K.; Michiba H.; Fujii M.; Tanaka K. (2020)
    © 2020 Elsevier Ltd Acrolein, a highly reactive α,β-unsaturated aldehyde, is a compound to which humans are exposed in many different situations and often causes various human diseases. This paper summarizes the reports ...
  • In vivometal-catalyzed SeCT therapy by a proapoptotic peptide 
    Ahmadi P.; Muguruma K.; Chang T.C.; Tamura S.; Tsubokura K.; Egawa Y.; Suzuki T.; Dohmae N.; Nakao Y.; Tanaka K. (2021)
    Selective cell tagging (SeCT) therapy is a strategy for labeling a targeted cell with certain chemical moietiesviaa catalytic chemical transformation in order to elicit a therapeutic effect. Herein, we report a cancer ...
  • Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation 
    Pradipta A.R.; Ahmadi P.; Terashima K.; Muguruma K.; Fujii M.; Ichino T.; Maeda S.; Tanaka K. (2021)
    Cytotoxic anticancer drugs used in chemotherapy are often antiproliferative agents that preferentially kill rapidly growing cancer cells. Their mechanism relies mainly on the enhanced proliferation rate of cancer cells and ...

Поиск в электронном архиве

Просмотр

Моя учетная запись